FDA Okays First Biosimilar for Multiple Sclerosis ...Middle East

Medscape - News
Sandoz's natalizumab-sztn injection (Tyruko) is on par with Biogen's Tysabri (natalizumab) for treatment of relapsing forms of MS, the FDA said in approving the first biosimilar to treat MS. Medscape Medical News

Hence then, the article about fda okays first biosimilar for multiple sclerosis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays First Biosimilar for Multiple Sclerosis )

Apple Storegoogle play

Last updated :

Also on site :